TLR4 and metabolic dysfunction-associated steatotic liver disease: Research elucidates a novel HMGB1-mediated inflammatory pathway in Non-Alcoholic Fatty Liver Disease (NAFLD), revealing a redox signaling mechanism where ONOO-, formed through NADPH oxidase activation, plays a pivotal role in TLR-4 activation and cytokine release (150).